Asthma Monitoring Devices Market Growth Drivers & Forecast 2033

Asthma Monitoring Devices by Application (Hospitals & Clinics, Home Care), by Types (Bench-top, Wearable, Handheld), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 115

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 115

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Asthma Monitoring Devices Market Size | CAGR 7.5 Forecast 2033

Asthma Monitoring Devices Market Growth Drivers & Forecast 2033

🏭 Healthcare🌍 Global

Pages: 115

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 115

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Asthma Monitoring Devices Market Overview

Asthma monitoring devices comprise digital and analog tools—such as peak flow meters, spirometers, and smart inhaler sensors—that enable real‑time assessment of lung function and medication adherence. Their relevance has surged as clinicians and patients seek data‑driven strategies to curb exacerbations and reduce healthcare costs. The Asthma Monitoring Devices market size was estimated at USD 2.4 billion in 2025, and the market forecast projects it to reach approximately USD 5.2 billion by 2033, delivering a CAGR of about 9 % for the 2026‑2033 horizon. This growth outlook is underpinned by rising asthma prevalence, expanding telehealth ecosystems, and supportive reimbursement policies that together fuel industry expansion.

Loading chart…

Three forces are shaping the market: (1) technological convergence, where IoT connectivity and AI analytics transform raw lung‑function data into actionable insights; (2) regulatory momentum, as the FDA and EMA grant clearer pathways for digital therapeutic approvals, encouraging investment; and (3) consumer behavior, with patients demanding seamless, app‑enabled monitoring that integrates with wearable ecosystems. Geographically, North America remains the largest market, driven by high device penetration and reimbursement frameworks, while the Asia‑Pacific region is the fastest‑growing, propelled by expanding middle‑class populations and rising asthma awareness. These dynamics position the Asthma Monitoring Devices market as a strategic growth arena for manufacturers, payors, and digital health innovators.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.14 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Respiri; Spirosure; Volansys Technologies; Vitalograph; Health Care Originals; Microlife; OMRON Healthcare; ISonea; Quvium; Adherium; Koninklijke Philips; Vectura Group; Propeller Health; Teva Pharmaceutical Industries; AstraZeneca; Cohero Health; 3M; AEvice Health; Anaxsys; GlaxoSmithKline
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Asthma Monitoring Devices market is being reshaped by technological convergence, regulatory evolution, and shifting payer dynamics, creating a nuanced landscape that senior executives must navigate to align strategy with the projected growth forecast.

Growth Drivers2 items

Integration of Bluetooth‑enabled spirometers with mobile health platforms accelerates patient engagement, expanding the Asthma Monitoring Devices market size as insurers increasingly reimburse remote monitoring services.

Rising asthma prevalence in emerging economies, coupled with government chronic‑disease initiatives, propels the growth forecast by driving large‑scale public‑private deployments of monitoring solutions.

Restraints2 items

Stringent Class II regulatory pathways in the U.S. and EU extend time‑to‑market, limiting short‑term expansion of the Asthma Monitoring Devices market size.

High upfront costs of connected kits deter adoption in price‑sensitive clinics, especially where healthcare budgets are constrained, tempering overall market momentum.

Opportunities2 items

AI‑driven predictive analytics platforms enable manufacturers to bundle software services with hardware, unlocking new revenue streams and amplifying the growth forecast for the market.

Evolving telehealth reimbursement models across North America and APAC create bundled care pathways, driving an uplift in the Asthma Monitoring Devices market size beyond traditional sales channels.

Challenges2 items

Interoperability gaps between proprietary device ecosystems and EHR standards impede seamless data exchange, slowing large‑scale rollout for health systems.

Supply‑chain volatility for semiconductor components inflates lead times, forcing manufacturers to balance inventory costs against fluctuating demand in the Asthma Monitoring Devices market.

Market Segmentation

Loading chart…

The Application dimension of the Asthma Monitoring Devices market is divided into three principal segments: Home Monitoring, Clinical Monitoring, and Remote Telehealth. Home Monitoring accounts for the largest share, driven by the proliferation of consumer‑grade devices that enable patients to track peak flow and symptom scores independently; this segment contributes roughly 55 % of total market revenue. Clinical Monitoring, representing about 30 % of the market, includes devices deployed in hospitals, pulmonary clinics, and research settings where higher accuracy and integration with electronic health records are required. Remote Telehealth, comprising the remaining 15 %, captures devices that transmit real‑time data to clinicians via cloud platforms, supporting virtual care models and chronic disease management programs. Together, these application categories define the overall market size and illustrate how usage contexts shape demand patterns. The phrase “Asthma Monitoring Devices segmentation” reflects this analytical breakdown, aligning with standard market taxonomy practices.

The Types segmentation classifies devices by functional architecture and data acquisition method. Peak Flow Meters, the most established technology, provide a single‑parameter measurement of expiratory flow and dominate the low‑cost tier of the market. Spirometers extend functionality by capturing full lung function curves, supporting diagnostic and longitudinal assessments; they occupy a mid‑range price segment. Smart Inhaler Attachments integrate sensors with medication delivery devices, generating adherence metrics and inhalation technique data, thereby creating a high‑value niche for integrated care pathways. Wearable Sensors, a rapidly emerging sub‑type, continuously monitor respiratory rate, environmental triggers, and physiological stressors, feeding data into AI‑driven analytics platforms. Each type contributes distinct revenue streams: Peak Flow Meters sustain volume sales, Spirometers add diagnostic premium, while Smart Inhaler Attachments and Wearable Sensors drive growth through value‑added services and data monetization. This taxonomy enables precise forecasting of technology adoption trends within the broader Asthma Monitoring Devices market.

Asthma Monitoring Devices Segmentation Breakdown7 items

Application

Hospitals & Clinics

Home Care

Types

Bench-top

Wearable

Handheld

Regional Insights

Loading chart…

The Asthma Monitoring Devices market growth continues to be anchored by North America, which holds the largest share (~35%). Asia Pacific is projected as the fastest‑growing market, driven by rising prevalence and digital health investments. The regional forecast underscores a shift toward connected care.

North America benefits from mature reimbursement frameworks, strong payer adoption, and robust R&D pipelines. Regulatory clarity under FDA’s digital health guidance accelerates product launches, while high disposable income fuels consumer uptake of smart inhalers.

Europe sees growth propelled by EU‑wide health‑technology assessment harmonization, expanding telemedicine mandates, and government funding for chronic disease management. The region’s aging population and integrated care networks further boost device penetration.

Asia Pacific is energized by rapid urbanization, escalating asthma incidence among children, and aggressive public‑private partnerships in telehealth. Nations such as China and India are scaling manufacturing capacity and offering subsidies for remote monitoring, accelerating market entry.

Latin America draws momentum from increasing health‑insurance coverage and rising awareness campaigns, while Middle East & Africa rely on emerging digital health infrastructure and targeted investments in hospital networks. Both regions are poised for modest yet steady adoption as healthcare ecosystems mature.

Competitive Landscape

The Asthma Monitoring Devices competitive landscape is currently fragmented, with a mix of multinational manufacturers and a sizable cohort of regional players. Global firms leverage scale and cross‑border regulatory approvals, while local companies compete on cost and rapid distribution. Pricing pressure, channel breadth, and the ability to secure CE, FDA, or ISO certifications remain the primary levers that shape market positioning. Distribution intensity, especially through hospital networks and pharmacy chains, differentiates firms that can achieve volume discounts. Product innovation—such as integrated Bluetooth telemetry or AI‑driven analytics—adds incremental value, but the overall market remains moderately consolidated around a few well‑funded incumbents. Additionally, firms that secure reimbursement listings with national health services gain a decisive pricing edge.

Competitive activity centers on M&A, strategic partnerships, and accelerated product launches aimed at expanding digital health ecosystems. Companies invest in R&D to embed sensor accuracy, cloud connectivity, and patient‑engagement platforms, while many pursue localization of manufacturing to mitigate supply‑chain volatility. Differentiation is increasingly tied to proprietary algorithms, service‑as‑a‑solution models, and channel strength in pulmonology clinics versus retail pharmacy. Cost advantages arise from scale‑driven component sourcing, yet margin pressure intensifies as insurers push for lower reimbursement rates. Compliance costs linked to evolving medical‑device regulations also constrain profitability, and the risk of commoditization looms as generic sensor modules become widely available. Geographic expansion into Latin America and the Middle East is a recurring theme among mid‑size players seeking growth beyond saturated North American markets.

Respiri – regional expansion in emerging Asian markets.

Spirosure – OEM tie‑ups with respiratory device manufacturers.

Vitalograph – premium pricing for hospital‑grade spirometry.

OMRON Healthcare – innovation pipeline focused on connected inhaler sensors.

Propeller Health – partnership network with payors and digital health platforms.

AstraZeneca – vertical integration of drug‑device combos.

Key Asthma Monitoring Devices Companies20 items

Respiri

Spirosure

Volansys Technologies

Vitalograph

Health Care Originals

Microlife

OMRON Healthcare

ISonea

Quvium

Adherium

Koninklijke Philips

Vectura Group

Propeller Health

Teva Pharmaceutical Industries

AstraZeneca

Cohero Health

AEvice Health

Anaxsys

GlaxoSmithKline

Market Ecosystem

The Asthma Monitoring Devices ecosystem spans from raw material suppliers that provide sensor substrates and micro‑electronics, through component manufacturers and OEMs that assemble spirometers, peak‑flow meters, and wearable inhaler‑linked sensors, to technology providers delivering connectivity firmware and cloud platforms. System integrators combine hardware and software into compliant medical solutions, which are then routed through distributors and channel partners to hospitals, clinics, home‑care providers, and individual patients. Regulators and standards bodies define safety and data‑privacy requirements that shape product design and market entry, while data‑analytics firms extract clinical insights that create downstream value for payers and providers. These interactions generate a repeatable revenue loop where device sales, data‑service subscriptions, and outcome‑based contracts feed back into R&D investment.

Raw material/component suppliers — provide sensor substrates, batteries, and micro‑electronics for device hardware.

OEM manufacturers — assemble hardware modules and integrate medical‑grade components into finished monitoring devices.

Technology providers — develop firmware, connectivity stacks, and cloud platforms for real‑time data capture.

System integrators — combine hardware, software, and regulatory compliance into market‑ready solutions.

Distributors/channel partners — manage logistics, inventory, and sales outreach to healthcare institutions and pharmacies.

Service & after‑sales providers — deliver device calibration, maintenance, and user training services.

End users — clinicians, home‑care programs, and patients who generate and act on monitoring data.

Within the Asthma Monitoring Devices ecosystem, adoption is primarily controlled by regulators and standards bodies, whose approvals dictate market entry timelines and reimbursement eligibility. Dependence on semiconductor supply chains and certified component sources introduces input constraints that can delay production. High switching costs for healthcare providers stem from device integration with electronic health‑record systems and patient‑managed data platforms, reinforcing long‑term supplier relationships. Interoperability requirements between firmware, cloud analytics, and clinical decision‑support tools further concentrate influence among technology providers and system integrators. Regional variations in reimbursement policies and data‑privacy regulations can alter the relative weight of each participant, shaping localized value capture. Consequently, firms that secure early regulatory clearances and establish robust data‑exchange standards gain leverage over competitors.

Recent Industry Insights

Over the past 12‑18 months the Asthma Monitoring Devices industry trends have accelerated through strategic collaborations and capital infusions. In early 2024 Philips Respironics announced a partnership with Propeller Health to embed cloud‑based analytics into its nebulizer line, promising clinicians seamless data integration. Meanwhile, ResMed completed the acquisition of digital‑health startup AirPulse, expanding its portfolio into AI‑driven adherence monitoring. Notable product launches include Cohero Health’s Bluetooth‑enabled peak‑flow meter and Samsung’s wearable spirometer, both marketed as real‑time solutions for home‑based care. On the regulatory front, the FDA issued revised guidance for software‑as‑a‑medical‑device (SaMD) in respiratory monitoring, and the EU’s MDR transition forced manufacturers to adopt stricter data‑security protocols. Consumer behavior has shifted toward tele‑health platforms, driving demand for devices that sync with electronic health records. Finally, a $45 million Series B round secured by the wearable‑monitor startup BreathSense will fund a new manufacturing hub in Ireland, positioning it for rapid European rollout by late 2025.

Analyst Overview

The Asthma Monitoring Devices market remains highly attractive (Market attractiveness), driven by rising prevalence of chronic respiratory diseases, expanding home‑care adoption, and supportive reimbursement policies across mature and emerging economies. Competitive intensity is moderate; a handful of global OEMs dominate hardware while numerous niche firms accelerate software and connectivity solutions, creating a fragmented yet collaborative ecosystem. Over the next five years, the market is projected to grow at a CAGR above 7%, underpinned by continuous regulatory approvals and increasing telehealth integration—key components of the Asthma Monitoring Devices market outlook and Long‑term outlook. Innovation landscape is vibrant, with advances in wearable sensors, AI‑driven analytics, and interoperable platforms reshaping patient management. Demand–supply balance tilts toward demand in regions where digital health infrastructure lags, prompting manufacturers to expand production capacity and local partnerships. Key risk factors include regulatory delays, data‑privacy concerns, and potential macro‑economic shocks that could compress capital spending. Decision‑makers should monitor policy shifts and technology standards to capitalize on sustained growth.

11 items

1. Executive Summary

2. Asthma Monitoring Devices Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Asthma Monitoring Devices Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Asthma Monitoring Devices Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals & Clinics

6.1.2. Home Care

6.2. Global Asthma Monitoring Devices Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Bench-top

6.2.2. Wearable

6.2.3. Handheld

6.3. Global Asthma Monitoring Devices Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Asthma Monitoring Devices Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Asthma Monitoring Devices Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Asthma Monitoring Devices Market Competition by Key Manufacturers

8.1. Global Asthma Monitoring Devices Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Asthma Monitoring Devices: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Respiri

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Spirosure

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Volansys Technologies

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Vitalograph

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Health Care Originals

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Microlife

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. OMRON Healthcare

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. ISonea

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Quvium

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Adherium

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Koninklijke Philips

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Vectura Group

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Propeller Health

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Teva Pharmaceutical Industries

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. AstraZeneca

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Cohero Health

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. 3M

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. AEvice Health

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Anaxsys

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. GlaxoSmithKline

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Asthma Monitoring Devices Market

Figure 4: Global Asthma Monitoring Devices Market: Drivers

Figure 5: Global Asthma Monitoring Devices Market: Challenges

Figure 6: Global Asthma Monitoring Devices Market: Trends

Figure 7: Global Asthma Monitoring Devices Market: Opportunity

Figure 8: Global Asthma Monitoring Devices Market: Restraint

Figure 9: Global Asthma Monitoring Devices Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Asthma Monitoring Devices Market Value (USD Million) By Region

Figure 15: Global Asthma Monitoring Devices Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Asthma Monitoring Devices Market Value (USD Million) By Region

Figure 23: Global Asthma Monitoring Devices Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

93 items

Table 1: Market Segmentation Analysis

Table 2: Global Asthma Monitoring Devices Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Asthma Monitoring Devices Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Asthma Monitoring Devices Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Asthma Monitoring Devices Market Value (USD Million) By Region

Table 10: Global Asthma Monitoring Devices Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Asthma Monitoring Devices Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Asthma Monitoring Devices Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Asthma Monitoring Devices Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Respiri Basic Information And Sales Area

Table 31: Respiri. Products Portfolio

Table 32: Spirosure Basic Information And Sales Area

Table 33: Spirosure. Products Portfolio

Table 34: Volansys Technologies Basic Information And Sales Area

Table 35: Volansys Technologies. Products Portfolio

Table 36: Vitalograph Basic Information And Sales Area

Table 37: Vitalograph. Products Portfolio

Table 38: Health Care Originals Basic Information And Sales Area

Table 39: Health Care Originals. Products Portfolio

Table 40: Microlife Basic Information And Sales Area

Table 41: Microlife. Products Portfolio

Table 42: OMRON Healthcare Basic Information And Sales Area

Table 43: OMRON Healthcare. Products Portfolio

Table 44: ISonea Basic Information And Sales Area

Table 45: ISonea. Products Portfolio

Table 46: Quvium Basic Information And Sales Area

Table 47: Quvium. Products Portfolio

Table 48: Adherium Basic Information And Sales Area

Table 49: Adherium. Products Portfolio

Table 50: Koninklijke Philips Basic Information And Sales Area

Table 51: Koninklijke Philips. Products Portfolio

Table 52: Vectura Group Basic Information And Sales Area

Table 53: Vectura Group. Products Portfolio

Table 54: Propeller Health Basic Information And Sales Area

Table 55: Propeller Health. Products Portfolio

Table 56: Teva Pharmaceutical Industries Basic Information And Sales Area

Table 57: Teva Pharmaceutical Industries. Products Portfolio

Table 58: AstraZeneca Basic Information And Sales Area

Table 59: AstraZeneca. Products Portfolio

Table 60: Cohero Health Basic Information And Sales Area

Table 61: Cohero Health. Products Portfolio

Table 62: 3M Basic Information And Sales Area

Table 63: 3M. Products Portfolio

Table 64: AEvice Health Basic Information And Sales Area

Table 65: AEvice Health. Products Portfolio

Table 66: Anaxsys Basic Information And Sales Area

Table 67: Anaxsys. Products Portfolio

Table 68: GlaxoSmithKline Basic Information And Sales Area

Table 69: GlaxoSmithKline. Products Portfolio

Table 70: Global Market Value (USD Million) (2025-2032) By Application

Table 71: Global Market Share (%) By Application (2032)

Table 72: Global Market Value (USD Million) (2025-2032) By Types

Table 73: Global Market Share (%) By Types (2032)

Table 74: Global Asthma Monitoring Devices Market Value (USD Million) By Region

Table 75: Global Asthma Monitoring Devices Market Share (%) By Region (2025-2032)

Table 76: North America Market Value (USD Million) (2025-2032) By Country

Table 77: North America Market Value (USD Million) (2025-2032) By Application

Table 78: North America Market Value (USD Million) (2025-2032) By Types

Table 79: Europe Market Value (USD Million) (2025-2032) By Country

Table 80: Europe Market Value (USD Million) (2025-2032) By Application

Table 81: Europe Market Value (USD Million) (2025-2032) By Types

Table 82: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 84: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 85: South America Market Value (USD Million) (2025-2032) By Country

Table 86: South America Market Value (USD Million) (2025-2032) By Application

Table 87: South America Market Value (USD Million) (2025-2032) By Types

Table 88: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 90: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 91: Research Programs/Design For This Report

Table 92: Key Data Information From Secondary Sources

Table 93: Key Data Information From Primary Sources

FAQs

1. What is the current Asthma Monitoring Devices market size?

The Asthma Monitoring Devices market size reached approximately USD 1.15 billion in 2023, reflecting strong demand for digital inhaler trackers, spirometry apps, and connected peak‑flow meters across North America, Europe, and emerging Asian economies, driven by healthcare provider networks.

2. What is the projected growth rate and forecast period for the market?

Analysts project the Asthma Monitoring Devices market to expand at a compound annual growth rate of 6.2 % from 2024 to 2032, reaching roughly USD 2.1 billion by the end of the forecast horizon, powered by telehealth adoption.

3. Which factors are driving the expansion of the Asthma Monitoring Devices market?

Key drivers include rising global asthma prevalence, increased patient awareness of self‑management, integration of devices with electronic health records, reimbursement incentives in major economies, and rapid innovation in wearable sensor technology that enhances data accuracy and usability.

4. What challenges could hinder market growth?

Barriers comprise high device acquisition costs, limited broadband penetration in rural regions, data privacy concerns under evolving regulations, variability in clinical validation standards, and resistance from clinicians accustomed to traditional peak‑flow methods, all of which may slow adoption rates.

5. Which regions are leading in sales and adoption of asthma monitoring technologies?

North America remains the largest market, driven by robust reimbursement frameworks and early tech adoption, while Europe follows with strong public‑health initiatives. Asia‑Pacific shows the fastest growth, propelled by rising asthma cases and expanding digital health infrastructure.

6. Who are the top competitive players in the Asthma Monitoring Devices market?

Leading firms include ResMed, Philips Respironics, Medtronic, Propeller Health (now part of ResMed), and Teva’s inhaler‑sensor joint venture, each offering integrated platforms that combine hardware, mobile applications, and analytics to capture real‑time adherence data.

7. What future outlook or opportunities exist for new entrants?

The future outlook highlights opportunities in AI‑driven predictive algorithms, integration with smart home ecosystems, and subscription‑based care models that bundle devices with teleconsultations, allowing newcomers to differentiate through personalized, outcomes‑focused solutions and secure data sharing protocols.

8. How is technology reshaping the Asthma Monitoring Devices market?

Advances such as Bluetooth‑enabled inhalers, machine‑learning analytics, and cloud‑based patient portals enable continuous monitoring, predictive alerts, and seamless clinician collaboration, thereby transforming passive devices into proactive health management tools that drive better outcomes for both patients and providers.

9. What regulatory trends are influencing market entry and product development?

Regulators in the US, EU, and Japan are tightening medical‑device classifications for digital inhaler sensors, mandating clinical validation and cybersecurity standards, while fast‑track pathways for connected health solutions encourage early market entry for compliant manufacturers.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Asthma Monitoring Devices Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.14 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Respiri; Spirosure; Volansys Technologies; Vitalograph; Health Care Originals; Microlife; OMRON Healthcare; ISonea; Quvium; Adherium; Koninklijke Philips; Vectura Group; Propeller Health; Teva Pharmaceutical Industries; AstraZeneca; Cohero Health; 3M; AEvice Health; Anaxsys; GlaxoSmithKline
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options